Related Experiment Video
Updated: Nov 17, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
PHB blocks endoplasmic reticulum stress and apoptosis induced by MPTP/MPP+ in PD models
Xiaohong Wang1, Dongyi Ding2, Lei Wu3
1School of Medicine, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Experimental & Translational Non-coding RNA ResearchNoncoding RNA Center, Yangzhou University, YangZhou 225001, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, China.
Abstract:
Ample empirical evidence suggests that mitochondrial dysfunction and endoplasmic reticulum (ER) stress play a crucial role in the pathogenesis of Parkinson's disease (PD). Prohibitin (PHB), a mitochondrial inner-membrane protein involved in mitochondrial homeostasis and function, may be involved in the pathogenesis of PD. We investigated the functional role of PHB in mitochondrial biogenesis and ER stress in methyl-4-phenylpyridinium (MPP +)-induced in vivo and in vitro models of PD. The overexpression of PHB in SH-SY5Y cells block ed cell death and the apoptosis induced by MPP + incubation. PHB also block ed the activation of ER stress markers, including glucose-regulated protein 78, while increasing the expression of Xbox- binding protein 1 and caspase-12. Moreover, the intracerebroventricular administration of the PHB overexpression vector greatly block ed motor dysfunction and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurodegeneration in the mouse model of PD. The production of reactive oxygen species, ER stress, and autophagic stress induced by MPTP were also significantly block ed in PD mice overexpressing PHB. Our results suggest that PHB blocks the dopaminergic-neuron depletion by preserving mitochondrial function and inhibiting ER stress. The genetic manipulation of PHB may feature potential as a treatment for PD.
Insights
Prohibitin (PHB) protein protects against Parkinson's disease (PD) by preserving mitochondrial function and reducing endoplasmic reticulum (ER) stress. Genetic manipulation of PHB shows potential for PD treatment.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Mitochondrial dysfunction and ER stress are implicated in Parkinson's disease (PD) pathogenesis.
- Prohibitin (PHB), a mitochondrial protein, may play a role in PD development.
Purpose of the Study:
- To investigate the functional role of PHB in mitochondrial biogenesis and ER stress in PD models.
- To evaluate the therapeutic potential of PHB manipulation in PD.
Main Methods:
- Utilized in vitro (MPP+-treated SH-SY5Y cells) and in vivo (MPTP-induced mouse model) PD models.
- Overexpressed PHB in neuronal cells and PD mice.
- Assessed cell death, apoptosis, ER stress markers, reactive oxygen species, and motor function.
Main Results:
- PHB overexpression protected against MPP+-induced cell death and apoptosis in SH-SY5Y cells.
- PHB inhibited ER stress markers and neurodegeneration in MPTP-treated mice.
- PHB reduced reactive oxygen species, ER stress, and autophagic stress in PD models.
Conclusions:
- PHB protects dopaminergic neurons by maintaining mitochondrial function and alleviating ER stress.
- Genetic manipulation of PHB presents a potential therapeutic strategy for Parkinson's disease.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
EPS and iPS Cells in Disease Research
The Intrinsic Apoptotic Pathway

